![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Bristol-Myers Squibb and Emory University announce partnership
Bristol-Myers Squibb Company and Emory University announced the formation of a strategic partnership to...
Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
Sanofi and the Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical...
Takeda’s exclusive distribution of Pfizer products in Japan
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Japan Inc. ("Pfizer") announced that they have...
Computer model successfully predicts drug side effects
A new set of computer models has successfully predicted negative side effects in hundreds...
New report estimates nearly 18 million cancer survivors in the US by 2022
The number of Americans with a history of cancer, currently estimated to be 13.7...
FDA approves Perjeta for people with HER2-positive metastatic breast cancer
Roche announced that the U.S. Food and Drug Administration has approved PerjetaTM.Perjeta is approved...
The challenges and opportunities of clinical trials in developing countries
Conducting more clinical trials in developing countries is of benefit because these populations are...
Novartis drug Gilenya® shows long-term efficacy and safety
New long-term data for Gilenya® (fingolimod), the only oral therapy approved to treat people...
Bristol-Myers Squibb Foundation announces $6 million in grants
The Bristol-Myers Squibb Foundation has announced $6 million in additional grants through its Together...
Alzheimer’s vaccine trial a success
A study led by Karolinska Institutet reports for the first time the positive effects...